Literature DB >> 22410640

The involvement of oxidants and NF-κB in cytokine-induced MMP-9 synthesis by bone marrow-derived osteoprogenitor cells.

Dror Ben-David1, Erella Livne, Abraham Z Reznick.   

Abstract

OBJECTIVE AND
DESIGN: The activity of immune cells affects the balance between bone mineralization and resorption carried out by the opposing actions of osteoblasts and osteoclasts, respectively. This study was aimed at determining the possible interaction between inflammatory conditions and collagen type I degrading MMP (mainly MMP-2 and MMP-9) synthesis and secretion in rat osteoprogenitors.
MATERIALS AND METHODS: The study was performed using primary rat bone marrow-derived osteoprogenitors during their advanced osteogenesis. Biochemical, immunohistochemical, and molecular biology techniques were used to investigate the influence of pro-inflammatory cytokines on MMP-2 and MMP-9 synthesis and secretion in osteoprogenitors.
RESULTS: Results indicated that both synthesis and secretion of MMPs (MMP-1, -2, -8, -9, and -13) were significantly induced after pro-inflammatory cytokine treatments, except MMP-2, whose levels remained unchanged. NF-κB (nuclear factor kappa-light chain enhancer of activated B cells) inhibition assays showed that induced MMP-9 secretion by inflammatory cytokines was mediated by activation of NF-κB via the classical pathway and that oxidants play a significant role in this signal transduction pathway. In contrast, no such effect was observed for synthesis of MMP-2.
CONCLUSIONS: These results indicate the possibility that inflammatory processes may trigger osteoblasts to absorb bone by secreting elevated levels of MMPs capable of degrading collagen type I, especially MMP-9 which is upregulated due to increased NF-κB transcription activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22410640     DOI: 10.1007/s00011-012-0461-7

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  44 in total

Review 1.  Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritis.

Authors:  Jorge A Roman-Blas; Sergio A Jimenez
Journal:  Int Rev Immunol       Date:  2008       Impact factor: 5.311

2.  Glutathione regulation of tumor necrosis factor-alpha-induced NF-kappa B activation in skeletal muscle-derived L6 cells.

Authors:  C K Sen; S Khanna; A Z Reznick; S Roy; L Packer
Journal:  Biochem Biophys Res Commun       Date:  1997-08-28       Impact factor: 3.575

3.  The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B.

Authors:  K N Schmidt; P Amstad; P Cerutti; P A Baeuerle
Journal:  Chem Biol       Date:  1995-01

4.  The effect of hindlimb immobilization on acid phosphatase, metalloproteinases and nuclear factor-kappaB in muscles of young and old rats.

Authors:  Marina Bar-Shai; Eli Carmeli; Raymond Coleman; Nimrod Rozen; Shoshan Perek; Dror Fuchs; Abraham Z Reznick
Journal:  Mech Ageing Dev       Date:  2005-02       Impact factor: 5.432

5.  Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity.

Authors:  G Bonizzi; J Piette; S Schoonbroodt; R Greimers; L Havard; M P Merville; V Bours
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

6.  Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-kappaB pathway.

Authors:  Mi-Young Song; Eun-Kyung Kim; Woo-Sung Moon; Jin-Woo Park; Hyung-Jin Kim; Hong-Seob So; Raekil Park; Kang-Beom Kwon; Byung-Hyun Park
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-21       Impact factor: 4.219

Review 7.  NF-kappaB signaling pathway and its therapeutic implications in human diseases.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong
Journal:  Int Rev Immunol       Date:  2008       Impact factor: 5.311

Review 8.  Osteoimmunology--the hidden immune regulation of bone.

Authors:  J Caetano-Lopes; H Canhão; J E Fonseca
Journal:  Autoimmun Rev       Date:  2008-08-21       Impact factor: 9.754

9.  Osteoporosis, inflammation and ageing.

Authors:  Lia Ginaldi; Maria Cristina Di Benedetto; Massimo De Martinis
Journal:  Immun Ageing       Date:  2005-11-04       Impact factor: 6.400

10.  H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor.

Authors:  M Meyer; R Schreck; P A Baeuerle
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

View more
  6 in total

1.  Effect of TRAF6 on the biological behavior of human lung adenocarcinoma cell.

Authors:  Lou Zhong; Fei Cao; Qingsheng You
Journal:  Tumour Biol       Date:  2012-10-04

2.  TRAF6 regulates proliferation, apoptosis, and invasion of osteosarcoma cell.

Authors:  Qingbing Meng; Minqian Zheng; Hongbing Liu; Changzhi Song; Wensheng Zhang; Juan Yan; Ling Qin; Xiaolan Liu
Journal:  Mol Cell Biochem       Date:  2012-08-12       Impact factor: 3.396

3.  TRAF6 is required for BLyS-mediated NF-κB signaling in multiple myeloma cells.

Authors:  Xinfeng Wang; Jingjing Wang; Hong Liu; Ruirong Xu; Runsheng Ding; Shenhua Jiang; Xudong Wang; Hongming Huang
Journal:  Med Oncol       Date:  2015-09-03       Impact factor: 3.064

4.  Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer.

Authors:  Derek C Marshall; Susan K Lyman; Scott McCauley; Maria Kovalenko; Rhyannon Spangler; Chian Liu; Michael Lee; Christopher O'Sullivan; Vivian Barry-Hamilton; Haben Ghermazien; Amanda Mikels-Vigdal; Carlos A Garcia; Brett Jorgensen; Arleene C Velayo; Ruth Wang; Joanne I Adamkewicz; Victoria Smith
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

5.  Molecular mechanisms of Huanglian jiedu decoction on ulcerative colitis based on network pharmacology and molecular docking.

Authors:  Jing Yang; Chaotao Tang; Ruiri Jin; Bixia Liu; Peng Wang; Youxiang Chen; Chunyan Zeng
Journal:  Sci Rep       Date:  2022-04-01       Impact factor: 4.379

6.  Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials.

Authors:  Yongzhao Zhu; Yinxue Yang; Yaolin Zhang; Guiliang Hao; Ting Liu; Libin Wang; Tingting Yang; Qiong Wang; Guangyi Zhang; Jun Wei; Yukui Li
Journal:  Stem Cell Res Ther       Date:  2014-04-10       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.